摘要

Antimicrobial stewardship programs (ASPs) are being implemented in various practice settings to assist with the challenges associated with the management of infectious diseases. Although the primary objective of such a program is optimization of clinical outcomes, many potential financial implications also exist. As departments of pharmacy work to implement and manage ASPs Within each unique practice site, there are many considerations which should be recognized by those involved in the formulary decision-making process. The intent of this article is to review the current state of ASPs from the perspective of a formulary decision-maker and raise awareness regarding the complex issues related to antimicrobial resistance, the current antimicrobial arsenal, potential ASP activities, and future directions. (Formulary. 2013;48:7-18.)